中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
—— |
N-[5-methyl-2-(pyridin-2-yl)-2H-1,2,3-triazol-4-yl]pyridine-3-carboxamide |
—— |
C14H12N6O |
|
—— |
5-methyl-1-(pyrimidin-2-yl)-1H-pyrazol-3-amine |
—— |
C8H9N5 |
|
—— |
1-benzyl-5-ethyl-1H-pyrazol-3-amine |
—— |
C12H15N3 |
|
—— |
N-(1-benzyl-5-ethyl-1H-pyrazol-3-yl)pyridine-3-carboxamide |
—— |
C18H18N4O |
|
—— |
ent-nigellamine A2 |
—— |
C39H42N2O7 |
|
—— |
4-[2-phenylethoxy]butanol |
—— |
C12H18O2 |
|
—— |
N-[5-methyl-1-(pyrimidin-2-yl)-1H-pyrazol-3-yl]pyridine-3-carboxamide |
—— |
C14H12N6O |
|
—— |
4-methyl-1-(pyrimidin-2-ylmethyl)-1H-pyrazol-3-amine |
—— |
C9H11N5 |
|
—— |
1,3-diaza-spiro [4.4] non-1-en-4-one monohydrochloride |
—— |
C7H10N2O*ClH |
|
—— |
5-methyl-2-(pyridin-2-yl)-2H-1,2,3-triazol-4-amine |
—— |
C8H9N5 |
|
—— |
N-[(R)-carbamoylphenylmethyl]-N-[(R)-4,6-difluoroindan-1-yl]nicotinamide |
—— |
C23H19F2N3O2 |
|
—— |
2-(2-hydroxy-3-chloropropyl)thio-5-chloropyrimidine |
—— |
C7H8Cl2N2OS |
|
—— |
1,3-dioxoisoindolin-2-yl nicotinate |
—— |
C14H8N2O4 |
|
—— |
doxorubicin tosylate |
1246449-85-3 |
C7H8O3S*C27H29NO11 |
|
—— |
N-(1H-pyrrolo[2,3-c]pyridin-2-ylmethyl)nicotinamide |
—— |
C14H12N4O |
|
—— |
(R)-4,6-difluoroindan-1-ylamine |
—— |
C9H9F2N |
|
—— |
N-2-pyridyldithiol-tetraoxaoctatriacontane-N-hydroxysuccinimide |
—— |
C39H65N3O17S2 |
|
—— |
1-(4-(hydroxymethyl)phenyl)-1,3,3-trimethylurea |
—— |
C11H16N2O2 |
|
—— |
tert-butyl 2-(methyl(2-(nicotinamido)ethyl)amino)ethylcarbamate |
—— |
C16H26N4O3 |
|
—— |
pent-4-yn-1-yl nicotinate |
—— |
C11H11NO2 |
|
—— |
2-(methoxymethyl)-6-nitroquinazolin-4(3H)-one |
—— |
C10H9N3O4 |
|
—— |
2-(3,4-methylenedioxybenzylmercapto)-acetohydroxamic acid |
—— |
C10H11NO4S |
|
—— |
(+)-dehydroabietylamine |
—— |
C20H31N |
|
—— |
2-[(2-methyl-5-tert-butoxycarbonylaminophenyl)amino]-4-(3-pyridyl)thiazole |
—— |
C20H22N4O2S |
|
—— |
((R)-((1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)(phenoxy)phosphoryloxy)methyl pivalate |
—— |
C21H28N5O6P |
|
—— |
methenyltetrahydromethanopterin |
—— |
C31H44N6O16P |
|
—— |
enigmol-tenofovir conjugate |
—— |
C27H51N6O5P |
|
—— |
5,7-dimethoxy-2-(4-(4-nicotinoylpiperazin-1-yl)phenyl)quinazolin-4(3H)-one |
—— |
C26H25N5O4 |
|
—— |
rel-N-[8-({(2R)-3-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-hydroxy-2-methylpropyl}oxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]amine |
—— |
C21H31N5O4 |
|
—— |
N-[6-chloro-4-(2,2,2-trifluoro-acetylamino)-9H-β-carbolin-8-yl]-nicotinamide |
—— |
C19H11ClF3N5O2 |
|
—— |
(4R,5R)-5-(benzyloxy)-1,2-dithian-4-yl phenyl ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate |
—— |
C26H30N5O5PS2 |
|
—— |
1,4-bis(3-N-oleylamino-propyl)piperazine |
—— |
C46H92N4 |
|
—— |
(R)-9-{2-[(dodecyldithioethyl)phosphate methoxy]propyl}adenine |
—— |
C23H42N5O4PS2 |
|
—— |
(-)-2-(2-benzenesulfonylethyl)-3-hydroxy-7-phenylheptanoic acid |
—— |
C21H26O5S |
|
—— |
rel-N-[8-({(2R)-3-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-hydroxy-2-methylpropyl}oxy)-7-methoxy-2,3-dihydroimidazo[1 ,2 ]quinazolin-5-yl]pyridine-3-carboxamide |
—— |
C27H34N6O5 |
|
—— |
((R)-((R)-((1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)(phenoxy)phosphoryloxy))methyl pivalate |
—— |
C21H28N5O6P |
|
—— |
[PtCl2(1(R),2-(R)-DACH)] |
—— |
C6H12Cl2N2Pt |
|
—— |
diethyl (((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate |
—— |
C13H22N5O4P |
|
—— |
phenyl P-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)-N-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenamido)ethyl)phosphonamidate |
—— |
C37H52N7O4P |
|
—— |
(S)-4-[4-[(4-chlorophenyl)-2-pyridylmethoxy]piperidin-1-yl]butanoic acid nicotinate |
1206695-39-7 |
C6H5NO2*C21H25ClN2O3 |
|
—— |
(5-(5-bromo-1-methyl-1H-indol-3-yl)-3-(4-bromophenyl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-3-yl)methanone |
—— |
C24H18Br2N4O |
|
—— |
tert-butyl (-)-[(4aR*,7aS*)-7a-(5-amino-2-fluorophenyl)-4,4a,5,6,7,7a-hexahydrocyclopenta[d][1,3]thiazin-2-yl]carbamate |
—— |
C18H24FN3O2S |
|
—— |
5-hydroxyisourate |
—— |
C5H3N4O4 |
|
—— |
(R)-9-{2-[(octadecyldithioethyl)phosphate methoxy]propyl}adenine |
—— |
C29H54N5O4PS2 |
|
—— |
tenofovir disoproxil citrate |
—— |
C6H8O7*C19H30N5O10P |
|
—— |
tenofovir disoproxil hydrogensulphate |
—— |
C19H30N5O10P*H2O4S |
|
—— |
9-[(R)-2-(phenyloxy(2,2-dimethylpropoxy-L-alaninyl)phosphonomethoxy)propyl]adenine |
—— |
C23H33N6O5P |
|
—— |
N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-3-pyridinecarboxamide |
—— |
C21H15N5O |
|
—— |
(S)-N-(3-(4-([1,1'-biphenyl]-4-ylmethoxy)phenyl)-1-((4-chloro-3-nitrophenyl)sulfonamido)-1- oxopropan-2-yl)nicotinamide |
—— |
C34H27ClN4O7S |
|
—— |
(1R,3S,4S)-2-(2-(3-acetyl-5-(nicotinamido)-1H-indazol-1-yl)acetyl)-N-(6-(trifluoromethyl)pyridin-2-yl)-2-azabicyclo[2.2.1]heptane-3-carboxamide |
—— |
C30H26F3N7O4 |
|